A new lens design aims to improve vision after cataract surgery

NCT ID NCT06428955

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests a new type of intraocular lens, the CT LUCIA 621P, designed to improve vision after cataract surgery. The lens has a special shape that may correct vision more precisely than standard lenses. Researchers will measure how well people see at distance and intermediate range three months after surgery. The study includes adults aged 50 and older having routine cataract surgery in both eyes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a hydrophobic aspheric monofocal intraocular lens with a non-constant aspheric optic profile, called CT LUCIA 621P
What this could lead to
If successful, this lens could provide sharper distance and intermediate vision after cataract surgery, potentially reducing the need for glasses.
What could go wrong
This is a small, early-phase study with only 44 participants, so results may not apply to everyone. Risks include typical surgical complications like infection or inflammation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huffman & Huffman PSC

    Lexington, Kentucky, 40509, United States

  • Price Vision Group

    Indianapolis, Indiana, 46260, United States

  • The Pennsylvania State University and Penn State Health

    Hershey, Pennsylvania, 17033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.